Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toner

Showing results (1121-1130 of 1,504) with videos related to

Pageof 151
Sort By:
Australian and New Zealand Journal of Medicine|June 1, 1996
Carboplatin dosing based on measurement of renal function--experience at the Peter MacCallum Cancer InstituteM J Millward, L K Webster, G C Toner, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 20, 2003
Thallium-201 scintigraphy--a predictor of tumour necrosis in soft tissue sarcoma following preoperative radiotherapy?P F M Choong, I Nizam, S Y K Ngan, et al.
Psycho-Oncology|June 29, 2018
A randomized controlled trial of a supportive expressive group intervention for women with a family history of breast cancerMary Jane Esplen, Molyn Leszcz, Jonathan Hunter, et al.
Journal of Biomedical Materials Research. Part A|July 8, 2010
Controlled induction of distributed microdeformation in wounded tissue via a microchamber array dressingBartholomew J Kane, George Younan, Douglas Helm, et al.
American Journal of Clinical Oncology|June 17, 1998
Dose escalation study of carboplatin and cyclophosphamide with filgrastim support: a phase I studyG C Toner, M Green, J F Bishop, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
The schedule-dependent effects of the novel antifolate pralatrexate and gemcitabine are superior to methotrexate and cytarabine in models of human non-Hodgkin's lymphomaLorraine E Toner, Radovan Vrhovac, Emily A Smith, et al.
Biophysical Journal|June 1, 1995
Dynamics of cell membrane permeability changes at supraphysiological temperaturesJ C Bischof, J Padanilam, W H Holmes, et al.
American Journal of Clinical Oncology|April 14, 2009
An open-label, single-arm phase two trial of gefitinib in patients with advanced or metastatic castration-resistant prostate cancerCarmel Pezaro, Mark A Rosenthal, Howard Gurney, et al.
Journal of Clinical Gastroenterology|July 23, 2009
Irritable bowel syndrome subtypes defined by Rome II and Rome III criteria are similarSpencer D Dorn, Carolyn B Morris, Yuming Hu, et al.
International Journal of Pharmaceutics|April 12, 2022
Optimization of topical formulations using a combination of in vitro methods to quantify the transdermal passive diffusion of drugsJoanna Hummer, Thomas Birngruber, Frank Sinner, et al.
Pageof 151

Showing results (1121-1130 of 1,504) with videos related to

Sort By:
Pageof 151
Australian and New Zealand Journal of Medicine|June 1, 1996
Carboplatin dosing based on measurement of renal function--experience at the Peter MacCallum Cancer InstituteM J Millward, L K Webster, G C Toner, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 20, 2003
Thallium-201 scintigraphy--a predictor of tumour necrosis in soft tissue sarcoma following preoperative radiotherapy?P F M Choong, I Nizam, S Y K Ngan, et al.
Psycho-Oncology|June 29, 2018
A randomized controlled trial of a supportive expressive group intervention for women with a family history of breast cancerMary Jane Esplen, Molyn Leszcz, Jonathan Hunter, et al.
Journal of Biomedical Materials Research. Part A|July 8, 2010
Controlled induction of distributed microdeformation in wounded tissue via a microchamber array dressingBartholomew J Kane, George Younan, Douglas Helm, et al.
American Journal of Clinical Oncology|June 17, 1998
Dose escalation study of carboplatin and cyclophosphamide with filgrastim support: a phase I studyG C Toner, M Green, J F Bishop, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
The schedule-dependent effects of the novel antifolate pralatrexate and gemcitabine are superior to methotrexate and cytarabine in models of human non-Hodgkin's lymphomaLorraine E Toner, Radovan Vrhovac, Emily A Smith, et al.
Biophysical Journal|June 1, 1995
Dynamics of cell membrane permeability changes at supraphysiological temperaturesJ C Bischof, J Padanilam, W H Holmes, et al.
American Journal of Clinical Oncology|April 14, 2009
An open-label, single-arm phase two trial of gefitinib in patients with advanced or metastatic castration-resistant prostate cancerCarmel Pezaro, Mark A Rosenthal, Howard Gurney, et al.
Journal of Clinical Gastroenterology|July 23, 2009
Irritable bowel syndrome subtypes defined by Rome II and Rome III criteria are similarSpencer D Dorn, Carolyn B Morris, Yuming Hu, et al.
International Journal of Pharmaceutics|April 12, 2022
Optimization of topical formulations using a combination of in vitro methods to quantify the transdermal passive diffusion of drugsJoanna Hummer, Thomas Birngruber, Frank Sinner, et al.
Pageof 151